Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
American Journal of Clinical Oncology|February 4, 2014
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality TherapyGrace J Kim, Matthew Koshy, Alexandra L Hanlon, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2006
Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancerPaul Ritch, Charles M Rudin, Jacob David Bitran, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2019
Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patientsLaurie E Steffen, Jennifer S Cheavens, Kevin E Vowles, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancerMartin J Edelman, Chandra P Belani, Mark A Socinski, et al.
Bioorganic & Medicinal Chemistry|January 8, 2013
Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepinesAtul Kondaskar, Shilpi Kondaskar, James C Fishbein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713Martin J Edelman, Kari Chansky, Laurie E Gaspar, et al.
Cancer Treatment Reviews|January 20, 2022
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncologyShreya M Shah, Elena V Demidova, Randy W Lesh, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 9, 2005
High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survivalKing F Kwong, Martin J Edelman, Mohan Suntharalingam, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
Journal of Palliative Medicine|November 27, 2024
End-of-Life Care in Hematology/Oncology FellowshipMadeline J Albert, Yang Liu, Asya Varshavsky, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
American Journal of Clinical Oncology|February 4, 2014
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality TherapyGrace J Kim, Matthew Koshy, Alexandra L Hanlon, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2006
Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancerPaul Ritch, Charles M Rudin, Jacob David Bitran, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2019
Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patientsLaurie E Steffen, Jennifer S Cheavens, Kevin E Vowles, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancerMartin J Edelman, Chandra P Belani, Mark A Socinski, et al.
Bioorganic & Medicinal Chemistry|January 8, 2013
Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepinesAtul Kondaskar, Shilpi Kondaskar, James C Fishbein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713Martin J Edelman, Kari Chansky, Laurie E Gaspar, et al.
Cancer Treatment Reviews|January 20, 2022
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncologyShreya M Shah, Elena V Demidova, Randy W Lesh, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 9, 2005
High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survivalKing F Kwong, Martin J Edelman, Mohan Suntharalingam, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
Journal of Palliative Medicine|November 27, 2024
End-of-Life Care in Hematology/Oncology FellowshipMadeline J Albert, Yang Liu, Asya Varshavsky, et al.
Pageof 19